Reinvented to keep you in control, it's where your edge begins with better information. Go from market noise to clarity in seconds with a real-time platform built to redefine how traders and investors digest financial news.
Visit www.marketflux.io
Here is Your Complete Market Rundown (08/03/2026):
Top Stories
Oil Plunges Over 5% as Trump Cancels Iran Strike, Announces Diplomatic Talks
Crude prices fell to three-week lows below $80 per barrel after President Trump called off planned attacks on Iran and announced talks resuming Monday. Despite diplomatic optimism, Iran rejected a U.S. proposal to reopen the Strait of Hormuz until hostilities end, while 3-5 million barrels daily continue flowing through southern shipping lanes.
Trump Claims Iran Talks at Critical Juncture, Warns of Last Chance for Deal
President Trump stated Iran negotiations are ongoing at Tehran’s request, focusing on reopening Strait of Hormuz and denuclearization. He warned this represents Iran’s “last chance” for agreement, with decisions expected within days. However, US officials clarified no new negotiations are planned, while Iran’s Foreign Ministry denied direct talks are occurring.
US and Japan Execute First Joint Yen Intervention in 15 Years
The US Treasury joined Japan in rare coordinated currency intervention after the yen hit a 40-year low, with Japan spending approximately $34 billion Friday following Thursday’s joint action. The unprecedented move aims to support the weakening yen against speculators, though questions remain about intervention sustainability and what concessions Washington may seek.
Company News
AstraZeneca Plc (AZN)
Performance Overview
1D Change: -8.89%
5D Change: -11.29%
News Volume: 97
Unusual Volume Factor: 14x
AstraZeneca Shares Plunge over 7% on Reports of $400 Billion Bristol Myers Squibb Merger Talks
AstraZeneca shares tumbled over 7% on Monday following reports that the pharmaceutical company held preliminary talks with Bristol Myers Squibb about a potential $400 billion merger that would create the world’s fourth-largest drugmaker by market value. The Financial Times reported the companies discussed a possible cash-and-stock combination in recent months, though the structure remains unclear and talks could still collapse. The market reaction sharply diverged between the two companies. While AstraZeneca shares dropped, Bristol Myers Squibb stock surged nearly 4% in premarket trading.
The proposed deal would combine AstraZeneca’s $264 billion market value with Bristol Myers’ $133 billion valuation. Analysts expressed skepticism about the strategic rationale behind the merger. Multiple firms, including Jefferies, called the potential tie-up a head scratcher and described themselves as perplexed by the logic. AstraZeneca currently ranks among the pharmaceutical industry’s strongest growth stories, leading analysts to question why the company would pursue this combination.
Jim Cramer suggested the rumors might be a fake out. Investors appeared to share these concerns, with the negative stock reaction signaling clear disapproval of the potential deal. The merger would create a cancer-drug giant, but analysts noted it could get really messy given the complexities involved in combining two major pharmaceutical companies. The FTSE 100 slipped as AstraZeneca’s decline weighed on the index. Separately, AstraZeneca announced the launch of its Imjudo drug in China and disclosed 8,855 shares issued under employee schemes.
Meta Platforms, Inc. (META)
Performance Overview
1D Change: 6.02%
5D Change: -0.59%
Meta Surges 6.5% as Wall Street Rewards AI Cloud Growth and Direct Monetization Strategy
Meta Platforms rallied sharply on Monday, climbing 6.1% to 6.6% as investors rewarded the company’s strong earnings results and accelerating cloud revenue growth. The stock gained approximately $36 alongside fellow tech giants Microsoft and Amazon, which rose 4.7% and 4.6% respectively, in a broader rally that added $830 billion in combined market value to major cloud and AI companies. Wall Street’s enthusiasm centered on Meta’s ability to demonstrate direct AI monetization rather than just heavy capital expenditure.
The market showed a clear preference for companies posting faster cloud growth and tangible revenue acceleration, with Meta extending gains after reporting its fifth consecutive quarter of cloud revenue improvement. This performance contrasted with companies facing investor skepticism over AI spending without immediate returns. CEO Mark Zuckerberg made announcements described as positive for shareholders, while also discussing Meta’s cloud ambitions and competitive positioning in the AI infrastructure space. Analysts from Rowan Street Capital noted that Meta’s fundamentals are outpacing its stock rally, with some price predictions suggesting 40% upside potential ahead. The company’s stock remained below $600, prompting analyst debate about buying opportunities at current levels. Meta received an invitation to the White House on Tuesday to discuss AI safety testing with U.S. government officials, alongside other tech companies including Anthropic.
This meeting reflects ongoing regulatory attention to AI development across the industry. The rally occurred amid a divided tech trade, with the market favoring direct AI monetization over pure infrastructure spending. Meta’s strong performance helped drive the Nasdaq up 2.1% as falling oil prices and positive tech earnings ignited a broader market rebound. Some portfolio managers suggested Meta represents a better investment opportunity than private alternatives like SpaceX. Separately, Meta faces ongoing litigation alongside other social media platforms from young users, families, and state attorneys general, with over 3,000 individual complaints pending. The company also confronts regulatory challenges in Australia regarding content costs.
The Boeing Company (BA)
Performance Overview
1D Change: 7.98%
5D Change: 10.41%
Boeing Shares Surge 7% on FAA Certification of 737 MAX 7 and Analyst Upgrade
Boeing stock rallied sharply Monday, leading the Dow Jones Industrial Average higher after receiving FAA certification for its 737 MAX 7 aircraft following a nearly decade-long review process. The regulatory approval marks a significant milestone for the planemaker, whose certification timeline was extended by two fatal crashes and ongoing quality concerns. The stock received additional momentum from a rare double upgrade by BNP Paribas, which cited fading plane-certification risks. Boeing’s lone bear analyst reversed position, projecting shares could double to $450 by 2030 as delivery momentum accelerates for both Boeing and Airbus.
Separately, Tajikistan’s Somon Air took delivery of its first 737 MAX aircraft leased from DAE, demonstrating continued commercial demand for the MAX family. The 737 MAX 7, the smallest variant in Boeing’s MAX lineup, can now enter commercial service after clearing the final regulatory hurdle. Boeing shares climbed approximately 5-7% during trading, representing the stock’s largest single-day gain since December. The positive developments helped drive a 711-point rally in the Dow, with Boeing and Microsoft leading the advance.
Marriott International, Inc. (MAR)
Performance Overview
1D Change: -7.0%
5D Change: -9.45%
Marriott Shares Slide 7.5% Despite Earnings Beat as Middle East Conflict Weighs on Revenue and Outlook
Marriott International reported second-quarter 2026 results that beat earnings expectations but missed on revenue, sending shares down as much as 7.5% on Monday. The hotel giant posted adjusted earnings per share of $3.19, exceeding the $3.05 estimate, while revenue of $7.07 billion fell short of the $7.22 billion consensus. The company cited ongoing Middle East conflicts as a significant headwind on sales and international performance.
Revenue per available room grew 5.0% domestically but declined 0.5% internationally, with overall RevPAR rising 3.4%. The geopolitical tensions in the Middle East created particular weakness in that region’s hotel demand. Despite the mixed quarterly results, Marriott raised its full-year outlook, now projecting adjusted EPS of $11.64 to $11.81, up from the previous range of $11.38 to $11.63. The company also increased its annual room revenue growth forecast, targeting 3% to 3.5% global RevPAR growth for 2026. Management highlighted record signings during the quarter and announced plans to return over $4.5 billion to shareholders through capital returns.
However, third-quarter guidance disappointed investors, with projected EPS of $2.74 to $2.82 falling below the $2.88 estimate. The softer near-term outlook, combined with the revenue miss and continued Middle East headwinds, overshadowed the earnings beat and raised full-year guidance. Analysts noted that strong domestic travel demand helped offset weaker international performance, though concerns about cooling guidance weighed on the stock throughout Monday’s trading session.
Geopolitics Events
Trump Criticizes Exxon and Chevron for Excessive Profits During Iran Conflict
President Trump publicly criticized major oil companies Exxon and Chevron for generating excessive profits from elevated oil prices amid the Iran conflict. He demanded the firms reduce retail prices, suggesting their earnings from supply shortages were unreasonable.
25 Democratic-Led States Sue Trump Administration Over Latest Global Tariffs
A coalition of 25 US states filed suit challenging the Trump administration's newest tariffs on imports from 60 trading partners. New York's Attorney General argues the tariffs are "impermissibly broad" and bypass required country-specific investigations, claiming they merely replace duties previously struck down by the Supreme Court.
White House to Host Major AI Companies for Framework Review Tuesday
The Trump administration has invited staffers from leading AI companies including OpenAI, Google, and Anthropic to the White House on Tuesday to review its artificial intelligence framework, according to The Information.
Crypto Events
Strategy Sells $102.4M in Bitcoin, Shifts Focus to Liquidity Management
Michael Saylor's Strategy sold 1,638 bitcoin last week worth $102.4 million, bringing 2026 total sales to $320.86 million. The company repurchased $81.2 million in STRC stock, signaling a strategic pivot toward liquidity over bitcoin accumulation.
American Bitcoin Posts Third Straight Loss Despite Growing Holdings to 8,300 BTC
Trump family-backed American Bitcoin reported its third consecutive quarterly loss as declining cryptocurrency valuations offset aggressive accumulation efforts. The miner increased its Bitcoin holdings to 8,300 BTC in Q2, up from 8,002 BTC earlier in the quarter. Meanwhile, Bitcoin surged above $63,800 following stronger-than-expected U.S. manufacturing data, with July's ISM PMI reaching 55.6. Separately, blockchain trackers identified a $165 million Bitcoin transfer from Trump Media, leaving minimal holdings.
Technology Events
Palantir Surges on AI-Driven Revenue Jump, Raises Full-Year Outlook
Palantir exceeded Q2 expectations with revenue jumping 93% on AI demand. U.S. commercial revenue soared nearly 150%. The company raised its full-year sales and income forecasts following the blowout quarter.
AWS AI Demand Drives Record Growth with Capacity Sold Through 2028
Amazon Web Services reported unprecedented growth as AI demand pushed its backlog to $496 billion, up 150% year-over-year. AWS CEO highlighted a shift from AI training to inference workloads, calling the potential business "just massive." The cloud division has sold out capacity through 2028, with analysts projecting AWS could become a trillion-dollar business.
Macro Events
Gold Holds Near $4,050 as Markets Assess Fed Rate Path Amid Cooling Geopolitical Tensions
Gold traded around $4,050 per ounce following a 1% gain in July, its first monthly increase since February, as traders evaluated the Federal Reserve's interest rate trajectory. Easing Middle East tensions reduced energy-driven inflation concerns. Treasury yields rose despite cooling inflation signals, with bond traders expressing skepticism about monetary policy direction. Weaker labor market data, including lower JOLTS figures, increased rate cut speculation. Markets assigned a one-in-three probability to the Fed holding rates in September. Factory orders showed neutral impact on trading sentiment.
Treasury Yields Decline as Markets Reassess Fed Rate Path
U.S. Treasury yields fell alongside the dollar as markets recalibrated expectations. BNP Paribas forecasts three Fed rate hikes beginning December, predicting continued yield increases as investors question Fed credibility. Treasuries climbed early week on oil movements and currency developments.
Corporate Actions Events
Curium to Acquire Lantheus for Up to $8 Billion in Cash Deal
Curium will acquire radiopharmaceutical company Lantheus in a transaction valued at up to $8 billion, offering $102.50 per share cash plus contingent value rights worth up to $12 per share.
Analyst Ratings Events
Circle Internet Falls on Morgan Stanley Downgrade to Underweight Despite TD Cowen Buy Rating
Circle Internet shares declined following Morgan Stanley's downgrade to Underweight with a reduced price target, though TD Cowen initiated coverage with a Buy rating, creating mixed analyst sentiment on the stock.
Healthcare Events
Pharma sector sees leadership changes across multiple companies
Medicus Pharma appointed Faisal Mehmud as CEO of UK subsidiary Antev, while Helus Pharma named Michael Halstead chief executive. Cue Biopharma brought on James Ahlers as CFO, and Anavex Life Sciences added two independent directors to its board.
© 2026 Advanced Vetting Algorithms Ltd.
